Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.
Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.
复制标题
DOI:
10.1186/1750-1172-9-73
复制
发表时间:
2014-05-08
影响因子:
3.7
通讯作者:
Gibson KM
中科院分区:
文献类型:
--
作者:
Vogel KR;Arning E;Wasek BL;McPherson S;Bottiglieri T;Gibson KM
Conventional therapy for patients with maple syrup urine disease (MSUD) entails restriction of protein intake to maintain acceptable levels of the branched chain amino acid, leucine (LEU), monitored in blood. However, no data exists on the correlation between brain and blood LEU with protein restriction, and whether correction in blood is reflected in brain. To address this question, we fed intermediate MSUD mice diets of 19% (standard) and 6% protein, with collection of sera (SE), striata (STR), cerebellum (CE) and cortex (CTX) for quantitative amino acid analyses. LEU and valine (VAL) levels in all brain regions improved on average 28% when shifting from 19% to 6% protein, whereas the same improvements in SE were on average 60%. Isoleucine (ILE) in brain regions did not improve, while the SE level improved 24% with low-protein consumption. Blood-branched chain amino acids (LEU, ILE, and VAL in sera (SE)) were 362-434 μM, consistent with human values considered within control. Nonetheless, numerous amino acids in brain regions remained abnormal despite protein restriction, including glutamine (GLN), aspartate (ASP), glutamate (GLU), gamma-aminobutyric acid (GABA), asparagine (ASN), citrulline (CIT) and serine (SER). To assess the specificity of these anomalies, we piloted preliminary studies in hyperphenylalaninemic mice, modeling another large neutral aminoacidopathy. Employing an identical dietary regimen, we found remarkably consistent abnormalities in GLN, ASP, and GLU. Our results suggest that blood amino acid analysis may be a poor surrogate for assessing the outcomes of protein restriction in the large neutral amino acidopathies, and further indicate that chronic neurotransmitter disruptions (GLU, GABA, ASP) may contribute to long-term neurocognitive dysfunction in these disorders.
登录
查看更多内容
影响因子:
15.9
作者:
Muelly, Emilie R.;Moore, Gregory J.;Strauss, Kevin A.
通讯作者:
Strauss, Kevin A.
影响因子:
8
作者:
Morton, DH;Strauss, KA;Kelley, RI
通讯作者:
Kelley, RI
影响因子:
4.7
作者:
DODD, PR;WILLIAMS, SH;JOHNSTON, GAR
通讯作者:
JOHNSTON, GAR
影响因子:
3.5
作者:
Brunetti-Pierri, Nicola;Lanpher, Brendan;Lee, Brendan
通讯作者:
Lee, Brendan
影响因子:
13.5
作者:
Skvorak, Kristen J.;Dorko, Kenneth;Marongiu, Fabio;Tahan, Veysel;Hansel, Marc C.;Gramignoli, Roberto;Gibson, K. Michael;Strom, Stephen C.
通讯作者:
Strom, Stephen C.